Samples should not be taken from patients receiving therapy with high biotin doses (i.e. > 5 mg/day) until at least 8 hours following the last biotin administration.
Immediately following collection, thoroughly mix sample by gently inverting 5 times
Gold:
Red:
Immediatley following collection, mix sample thoroughly by gently inverting 8 - 10, times to prevent clotting
Spin within two (2) hours of sample collection
Lt green plasma separator (PST)
Refrigerated (preferred) - 2 days
Ambient - 1 day
Frozen - 6 months
Electrochemiluminescence immunoassay (ECLIA)
Healthy Post menopause | <5 - 138 pg/mL |
Healthy pregnant - 1st Trimester | 154 - 3243 pg/mL |
Healthy pregnant - 2nd trimester | 1561 - 21280 pg/mL |
Healthy pregnant - 3rd trimester | 8525 - > 30000 pg/mL |
Female - Follicular | 30.9 - 90.4 pg/mL |
Female - Ovulation | 60.4 - 533 pg/mL |
Female - Luteal | 60.4 - 232 pg/mL |
Female - early Follicular | 20.5 - 62.8 pg/mL |
Female - intermediate Follicular | 26 - 79.8 pg/mL |
Female - late Follicular | 49.5 - 233 pg/mL |
Female - Ovulation | 60.4 - 602 pg/mL |
Female - early Luteal | 51.1 - 179 pg/mL |
Female - intermediate Luteal | 66.5 - 305 pg/mL |
Female - late luteal | 30.2 - 222 pg/mL |